Partner Investment Management, L.P. (CIK: 0001442276) is a financial institution headquartered at Four Embarcadero Center, Suite 3500, San Francisco, California 94111. The firm regularly files Form 13F with the U.S. Securities and Exchange Commission (SEC), disclosing its equity holdings and investment positions.
As of the latest reporting period (2019-12-31), the institution manages a portfolio valued at $13.93 M, comprising 41 distinct securities. Over its filing history, it has submitted 30 Form 13F reports.
To view the institution’s full SEC filing history:
🔗 View All SEC Filings
Q4 2019 — Top-10 concentration: 48.5%. Quarterly turnover: 10.5%. ▲ 13 new, +3 added, −23 reduced, ×37 exited.
| Name | Shares | Market Value | Weight | Change | Activity |
|---|---|---|---|---|---|
|
Audentes Therapeutics
N/A
|
17,795 | $1.06 M | 7.65% | ▼ 7,575 | Reduce -29.9% |
|
Alexion Pharmaceuticals
N/A
|
8,421 | $911,000 | 6.54% | ▼ 13,715 | Reduce -62.0% |
|
Allena Pharmaceuticals
N/A
|
284,285 | $776,000 | 5.57% | ||
| 10,898 | $708,000 | 5.08% | ▼ 17,604 | Reduce -61.8% | |
| 3,699 | $608,000 | 4.37% | ▼ 8,859 | Reduce -70.5% | |
| 3,800 | $552,000 | 3.96% | ▼ 14,419 | Reduce -79.1% | |
| 1,839 | $546,000 | 3.92% | ▲ 1,839 | New Buy | |
|
Nevro
N/A
|
4,515 | $531,000 | 3.81% | ▼ 1,252 | Reduce -21.7% |
| 1,669 | $504,000 | 3.62% | ▲ 1,669 | New Buy | |
| 1,347 | $494,000 | 3.55% | ▲ 1,347 | New Buy |